Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thu-Lan Kelly

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Drugs & Aging|December 19, 2022
Correction to: Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trialGereltuya Dorj, Nibu Parameswaran Nair, Luke Bereznicki, et al.
Pharmacoepidemiology and Drug Safety|March 13, 2024
Medicine utilization studies in Australian individual-level dispensing data: A blinded, multi-center replicated analysisMalcolm B Gillies, Chrianna Bharat, Ximena Camacho, et al.
Critical Care Explorations|August 22, 2024
Impact of Hemoglobin Levels on Composite Cardiac Arrest or Stroke Outcome in Patients With Respiratory Failure Due to COVID-19Shi Nan Feng, Thu-Lan Kelly, John F Fraser, et al.
Drug Safety|April 19, 2023
Prevalence and Preventability of Adverse Medicine Events in a Sample of Australian Aged-Care Residents: A Secondary Analysis of Data from the ReMInDAR TrialLisa M Kalisch Ellett, Gerel Dorj, Andre Q Andrade, et al.
Heart & Lung : the Journal of Critical Care|July 5, 2024
Stroke in critically ill patients with respiratory failure due to COVID-19: Disparities between low-middle and high-income countriesDenise Battaglini, Thu-Lan Kelly, Matthew Griffee, et al.
Critical Care Medicine|April 3, 2023
Cerebrovascular Complications of COVID-19 on Venovenous Extracorporeal Membrane OxygenationAkram M Zaaqoq, Matthew J Griffee, Thu-Lan Kelly, et al.
The Neurohospitalist|November 15, 2024
Neurological Complications and Outcomes in Critically Ill Patients With COVID-19: Results From International Neurological Study Group From the COVID-19 Critical Care ConsortiumSyed Ameen Ahmad, Yunis Mayasi, Thu-Lan Kelly, et al.
BMJ Open|September 21, 2022
Dual mobility versus conventional total hip arthroplasty in femoral neck fractures (DISTINCT): protocol for a registry-nested, open-label, cluster-randomised crossover trialJohn E Farey, Tamara Hooper, Tania Alland, et al.
Bone & Joint Open|August 3, 2025
Dual-mobIlity verSus conventional Total hip arthroplasty In femoral Neck fractures, a registry-nested, open-label, Cluster-randomized crossover Trial (DISTINCT) : statistical analysis plan, John E Farey, Tania Alland, et al.
Age and Ageing|April 23, 2022
Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised controlled trial (the ReMInDAR trial)Elizabeth E Roughead, Nicole L Pratt, Gaynor Parfitt, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Drugs & Aging|December 19, 2022
Correction to: Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trialGereltuya Dorj, Nibu Parameswaran Nair, Luke Bereznicki, et al.
Pharmacoepidemiology and Drug Safety|March 13, 2024
Medicine utilization studies in Australian individual-level dispensing data: A blinded, multi-center replicated analysisMalcolm B Gillies, Chrianna Bharat, Ximena Camacho, et al.
Critical Care Explorations|August 22, 2024
Impact of Hemoglobin Levels on Composite Cardiac Arrest or Stroke Outcome in Patients With Respiratory Failure Due to COVID-19Shi Nan Feng, Thu-Lan Kelly, John F Fraser, et al.
Drug Safety|April 19, 2023
Prevalence and Preventability of Adverse Medicine Events in a Sample of Australian Aged-Care Residents: A Secondary Analysis of Data from the ReMInDAR TrialLisa M Kalisch Ellett, Gerel Dorj, Andre Q Andrade, et al.
Heart & Lung : the Journal of Critical Care|July 5, 2024
Stroke in critically ill patients with respiratory failure due to COVID-19: Disparities between low-middle and high-income countriesDenise Battaglini, Thu-Lan Kelly, Matthew Griffee, et al.
Critical Care Medicine|April 3, 2023
Cerebrovascular Complications of COVID-19 on Venovenous Extracorporeal Membrane OxygenationAkram M Zaaqoq, Matthew J Griffee, Thu-Lan Kelly, et al.
The Neurohospitalist|November 15, 2024
Neurological Complications and Outcomes in Critically Ill Patients With COVID-19: Results From International Neurological Study Group From the COVID-19 Critical Care ConsortiumSyed Ameen Ahmad, Yunis Mayasi, Thu-Lan Kelly, et al.
BMJ Open|September 21, 2022
Dual mobility versus conventional total hip arthroplasty in femoral neck fractures (DISTINCT): protocol for a registry-nested, open-label, cluster-randomised crossover trialJohn E Farey, Tamara Hooper, Tania Alland, et al.
Bone & Joint Open|August 3, 2025
Dual-mobIlity verSus conventional Total hip arthroplasty In femoral Neck fractures, a registry-nested, open-label, Cluster-randomized crossover Trial (DISTINCT) : statistical analysis plan, John E Farey, Tania Alland, et al.
Age and Ageing|April 23, 2022
Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised controlled trial (the ReMInDAR trial)Elizabeth E Roughead, Nicole L Pratt, Gaynor Parfitt, et al.
Pageof 5